<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[blood pressure Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/blood+pressure.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to blood pressure]]></description>
	<s:counts start="0" returned="20" found="54" />
	<language>en-us</language>
	<item>
		<title><![CDATA[List of 56 Drugs That Should Not Be Mixed With Viagra Contains Some Surprises]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000558/list-of-56-drugs-that-should-not-be-mixed-with-viagra-contains-some-surprises/]]></link>
		<description><![CDATA[Public Citizen has published a list of 56 drugs that interact badly with erectile dysfunction pills such as Pfizer's Viagra. Public Citizen's WorstPills.com site reports:  In combination with ED drugs, these 56 drugs can cause dangerous falls in blood pressure that could lead to a heart attack or stroke;...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 06 Jan 2009 07:22:58 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[Blood Pressure]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Newspapers]]></title>
		<link><![CDATA[http://www.bnet.com/2422-17910_23-209210.html]]></link>
		<description><![CDATA[The decline of the newspaper means ransom notes, papier-mÃ¢chÃ© and slacker gift wrapping will never be the same.]]></description>
		<s:doctype><![CDATA[Videos]]></s:doctype>
		<pubDate>Wed, 02 Jul 2008 04:16:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/nyse.html"><![CDATA[nyse]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq.html"><![CDATA[nasdaq]]></category>
		<category domain="http://resources.bnet.com/topic/invest.html"><![CDATA[invest]]></category>
		<category domain="http://resources.bnet.com/topic/investing.html"><![CDATA[investing]]></category>
		<category domain="http://resources.bnet.com/topic/stock++stock+exchange.html"><![CDATA[stock  stock exchange]]></category>
		<category domain="http://resources.bnet.com/topic/stocks.html"><![CDATA[stocks]]></category>
		<category domain="http://resources.bnet.com/topic/wallstrip.html"><![CDATA[wallstrip]]></category>
		<category domain="http://resources.bnet.com/topic/julie+alexandria.html"><![CDATA[julie alexandria]]></category>
		<category domain="http://resources.bnet.com/topic/howard+lindzon.html"><![CDATA[howard lindzon]]></category>
		<category domain="http://resources.bnet.com/topic/fish+wrap.html"><![CDATA[fish wrap]]></category>
		<category domain="http://resources.bnet.com/topic/periodical.html"><![CDATA[periodical]]></category>
		<category domain="http://resources.bnet.com/topic/sony+bravia.html"><![CDATA[sony bravia]]></category>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/sports+section.html"><![CDATA[sports section]]></category>
		<category domain="http://resources.bnet.com/topic/new+york+times.html"><![CDATA[new york times]]></category>
		<category domain="http://resources.bnet.com/topic/craigslist.html"><![CDATA[craigslist]]></category>
		<category domain="http://resources.bnet.com/topic/usa+today.html"><![CDATA[usa today]]></category>
		<category domain="http://resources.bnet.com/topic/newspapers.html"><![CDATA[newspapers]]></category>
		<category domain="http://resources.bnet.com/topic/newspaper.html"><![CDATA[Newspaper]]></category>
	</item>
	<item>
		<title><![CDATA[Omron Makes Blood Pressure Monitoring Easy for Women at Any Stage of Life, Including Pregnancy]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m4PRN/is_2008_May_8/ai_n25401401]]></link>
		<description><![CDATA[New Women's Advanced Blood Pressure Monitor Elite 7300W is Designed and Clinically Validated Specifically for Women]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 08 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/omron+corp..html"><![CDATA[Omron Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[women]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OMRNY</category>
		<category domain="tickers">OMRNY</category>
	</item>
	<item>
		<title><![CDATA[Lower your blood pressure when it comes to securing patient data]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=343401]]></link>
		<description><![CDATA[Protecting patient data is a huge task. Compliance regulations make the challenge even bigger. In this IBM Healthcare Security Executive Kit, you'll learn how to safeguard data more effectively, reduce regulatory compliance risks and lower operating expenses associated with security. You'll even see how to dispose of old equipment in...]]></description>
		<s:doctype><![CDATA[Resource centers]]></s:doctype>
		<pubDate>Tue, 01 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/information+security.html"><![CDATA[Information Security]]></category>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[Blood Pressure]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/ibm+corp..html"><![CDATA[IBM Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[Security]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IBM</category>
		<category domain="tickers">IBM</category>
	</item>
	<item>
		<title><![CDATA[Merck's Investigational CETP-Inhibitor, MK-0859 , Produced Positive Effects on Lipids with No Observed Blood Pressure Changes in Phase IIb Study]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_4/ai_n27397533]]></link>
		<description><![CDATA[WHITEHOUSE STATION, N.J. -- In Phase IIb study results presented by Merck & Co., Inc., anacetrapib (formerly known as MK-0859), its investigational selective cholesteryl ester transfer protein CETP inhibitor, significantly reduced LDL-cholesterol (LDL-C) and Apolipoprotein B Apo B and increased HDL-cholesterol (HDL-C) and Apolipoprotein A-1 (Apo A-1) both as monotherapy...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 04 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[eFoodSafety.com, Inc. Announces: Expanded Study Results Confirm Additional Benefits from Cinnechol&#153; in Reducing Blood Pressure as Well as Cholesterol Levels]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_27/ai_n27389178]]></link>
		<description><![CDATA[SCOTTSDALE, Ariz. -- eFoodSafety.com, Inc. (OTCBB:EFSF) is pleased to confirm that during the initial phase of testing Cinnechol[TM] for the treatment of elevated cholesterol, an expanded study showed a very strong and totally unexpected benefit of reducing blood pressure among study participants showing symptoms of hypertension. Within this group taking...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefit.html"><![CDATA[benefit]]></category>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Health Risk Morning Hypertension - Now Detectable With the New Omron M10-IT Digital Automatic Blood Pressure Monitor.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200708/ai_n23649119]]></link>
		<description><![CDATA[HOOFDDORP, The Netherlands, August 31 /PRNewswire/ --     Morning  Hypertension has been identified as a major health risk for those  susceptible to high blood pressure. When waking up, many of us  experience a condition called "Morning Surge"  HOOFDDORP, The Netherlands, August 31 /PRNewswire/...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 31 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/omron+corp..html"><![CDATA[Omron Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OMRNY</category>
		<category domain="tickers">OMRNY</category>
	</item>
	<item>
		<title><![CDATA[Medical Device Company CVRx Adopts Configurable ARC® Core For Implantable Blood Pressure Reduction Device]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_July_11/ai_n27300772]]></link>
		<description><![CDATA[ST. ALBANS, England -- ARC International (LSE:ARK) today announced that CVRx([R]), Inc. has chosen a member of the configurable ARC([R]) 600 core family to drive its Rheos([TM]) Baroreflex Hypertension Therapy([TM]) System. CVRx chose a configurable ARC core because of its very small size, ability to operate using extremely low power,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 11 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/medical+device.html"><![CDATA[medical device]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Top Seven Workplace Plays and Maneuvers]]></title>
		<link><![CDATA[http://www.bnet.com/2403-13070_23-93274.html]]></link>
		<description><![CDATA[All office politicking relies upon a simple concept: the biggest help and the biggest hindrance to reaching your goals is other people. What's the right way to win friends and influence people? The most effective moves build alliances, sell your ideas, and solve problems. They also involve risk â€” so...]]></description>
		<s:doctype><![CDATA[Articles]]></s:doctype>
		<pubDate>Mon, 02 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[Alliance]]></category>
		<category domain="http://resources.bnet.com/topic/benefit.html"><![CDATA[Benefit]]></category>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[Blood Pressure]]></category>
		<category domain="http://resources.bnet.com/topic/bnet+feature.html"><![CDATA[BNET Feature]]></category>
		<category domain="http://resources.bnet.com/topic/career.html"><![CDATA[career]]></category>
		<category domain="http://resources.bnet.com/topic/caution.html"><![CDATA[Caution]]></category>
		<category domain="http://resources.bnet.com/topic/downtime.html"><![CDATA[Downtime]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/game.html"><![CDATA[Game]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/idea.html"><![CDATA[Idea]]></category>
		<category domain="http://resources.bnet.com/topic/job.html"><![CDATA[Job]]></category>
		<category domain="http://resources.bnet.com/topic/kelly+pate+dwyer.html"><![CDATA[Kelly Pate Dwyer]]></category>
		<category domain="http://resources.bnet.com/topic/leader.html"><![CDATA[Leader]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/newsletter.html"><![CDATA[Newsletter]]></category>
		<category domain="http://resources.bnet.com/topic/professional+development.html"><![CDATA[professional development]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/team.html"><![CDATA[Team]]></category>
		<category domain="http://resources.bnet.com/topic/team+management.html"><![CDATA[Team Management]]></category>
		<category domain="http://resources.bnet.com/topic/vision.html"><![CDATA[Vision]]></category>
		<category domain="http://resources.bnet.com/topic/workplace.html"><![CDATA[workplace]]></category>
	</item>
	<item>
		<title><![CDATA[Omron(R) Non-Invasive Blood Pressure Monitor with Augmentation Index's Utility Spurs Revision of Hypertension Treatment Guidelines.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200706/ai_n23640105]]></link>
		<description><![CDATA[KYOTO, Japan, June 29 /PRNewswire/ --    KYOTO, Japan, June 29 /PRNewswire/ --  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 29 Jun 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/omron+corp..html"><![CDATA[Omron Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OMRNY</category>
		<category domain="tickers">OMRNY</category>
	</item>
	<item>
		<title><![CDATA[Novartis Pursues Legal Actions to Defend Intellectual Property Rights for High Blood Pressure Medicine Lotrel Following US Court Ruling]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200705/ai_n19162947]]></link>
		<description><![CDATA[--  Novartis has a valid US patent for Lotrel -- a single-tablet     combination therapy for high blood pressure -- until December 2017, will     continue to enforce patent rights --  US judge extends temporary restraining order until May 29 but allows...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 21 May 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/intellectual+property.html"><![CDATA[intellectual property]]></category>
		<category domain="http://resources.bnet.com/topic/intellectual+property+right.html"><![CDATA[intellectual property right]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[OMRON Digital Thermometer Wins iF Product Design Gold Award; HEM-1010-E Blood Pressure Monitor Also Recognized]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0RRT/is_2007_April_10/ai_n27197628]]></link>
		<description><![CDATA[Tokyo, Japan, Apr 10, 2007 - JCN Newswire -  Omron Healthcare Co., Ltd., a wholly owned subsidiary of OMRON Corporation (TSE:6645; ADR: OMRNY) today announced that its i-Temp digital thermometer (model MC-670-E), which will debut in Europe this October, won a Gold Award at the iF Product Design Awards...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 10 Apr 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/omron+corp..html"><![CDATA[Omron Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/product+design.html"><![CDATA[product design]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OMRNY</category>
		<category domain="tickers">OMRNY</category>
	</item>
	<item>
		<title><![CDATA[Novartis&#39; Busy Week]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5292/is_200703/ai_n21233894]]></link>
		<description><![CDATA[A tablet that inhibits an enzyme produced by the kidney and an antifungal ointment were on the menu for Novartis last week. The Swiss drugmaker received approval from the U.S. Food and Drug Administration for Tekturna, a blood pressure medicine that is the first approved by the federal agency to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 12 Mar 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Repeat - Novartis Announces Efficacy Data on New Investigational High Blood Pressure Therapies at the American Society of Hypertension Annual Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200605/ai_n16363105]]></link>
		<description><![CDATA[--  Studies show Rasilez® aliskiren, investigational agent in a new     class of direct renin inhibitors, provides significant blood pressure     reductions, sustained over 24 hours  --  New Exforge® (amlodipine besylate/valsartan) data show dual     mechanism of action...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 17 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Novartis Announces Efficacy Data on New Investigational High Blood Pressure Therapies at the American Society of Hypertension Annual Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200605/ai_n16363146]]></link>
		<description><![CDATA[--  Studies show Rasilez® aliskiren, investigational agent in a new     class of direct renin inhibitors, provides significant blood pressure     reductions, sustained over 24 hours  --  New Exforge® (amlodipine besylate/valsartan) data show dual     mechanism of action...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 17 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[FDA Approves Higher Dose Formulations of Diovan HCT(R) (Valsartan/Hydrochlorothiazide) for Treatment of High Blood Pressure]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200605/ai_n16139094]]></link>
		<description><![CDATA[The U.S. Food and Drug Administration FDA approved two new, higher dose formulations of the high blood pressure medication Diovan HCT® (valsartan/hydrochlorothiazide): 320/12.5 mg and 320/25 mg.  The approval of the higher strengths of Diovan HCT provides more options to help physicians more effectively manage their patients' high blood...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/formulation.html"><![CDATA[formulation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[US Submission of Exforge(R) Accepted for Review By the FDA as a New Therapy Option for High Blood Pressure]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200604/ai_n16136756]]></link>
		<description><![CDATA[Novartis announced today that the new drug application NDA for Exforge® (amlodipine besylate/valsartan) was accepted for standard review by the US Food and Drug Administration FDA as a new treatment option for people with high blood pressure. The submission for EU approval was completed earlier in 2006. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Apr 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200511/ai_n23958739]]></link>
		<description><![CDATA[New Data Show Hypertensive Patients Taking Norvasc-Based Regimen Achieved                    Better Central Blood Pressure Control    Central Blood Pressure Shown to Be an Independent Predictor of Cardiovascular   ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/cafe.html"><![CDATA[Cafe]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Medtronic Evaluates Remote Monitoring of Heart Activity, Weight and Blood Pressure in Heart Failure Patients]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_May_3/ai_n13669315]]></link>
		<description><![CDATA[MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT), today announced it has begun a U.S. pilot evaluation with Carematix, Inc. to assess the efficacy and convenience of remotely monitoring physiological heart data, weight and blood pressure in the management of heart failure.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 03 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/medtronic+inc..html"><![CDATA[Medtronic Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/monitoring.html"><![CDATA[monitoring]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
		<category domain="tickers">MDT</category>
	</item>
	<item>
		<title><![CDATA[Omron Healthcare to Introduce New Upper Arm Blood Pressure Monitor]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn6209/is_20050425/ai_n24407962]]></link>
		<description><![CDATA[Omron Healthcare announced on April 21 that it will begin marketing HEM-5001 MediNote, a new model of its upper arm blood pressure monitor, on April 25. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 25 Apr 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/omron+corp..html"><![CDATA[Omron Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OMRNY</category>
		<category domain="tickers">OMRNY</category>
	</item>
</channel>
</rss>
